Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hematology Analyzer With Antibody Tests

By HospiMedica staff writers
Posted on 01 Sep 2005
A new high-volume automated hematology analyzer incorporates monoclonal antibody tests for additional cellular analysis. More...
The instrument has been cleared by the U.S. Food and Drug Administration (FDA).

The primary function of a hematology analyzer is to perform complete blood counts (CBCs), tests routinely ordered by doctors to assess a patient's overall health, and to screen for a variety of disorders such as anemia and infection. The Cell-Dyn Sapphire blue diode laser offers fluorescence and patented multi-angle polarized scatter separation (MAPSS) technology to provide advanced analysis of red blood cells, white blood cells, and platelets.

With its monoclonal antibody tests, the instrument also provides common flow cytometry capabilities, allowing some tests to be performed in the hematology laboratory versus being sent out to a specialized lab for processing. For example, one test can provide T-lymphocyte subset identification used in monitoring patients with HIV, while another monoclonal test allows the instrument to perform an immunologic platelet count to help make decisions regarding platelet transfusions.

"Our lab evaluated numerous pediatric samples using the Cell-Dyn Sapphire,” noted Mark Steele, M.D., hematology laboratory director, Children's Hospital Medical Center in Akron (OH, USA). "The instrument's fluorescent technology offers many unique utilities for patient sample analysis, including the ability to add monoclonal applications and potentially incorporate additional assays that may be used to better diagnose infection.”

The Sapphire analyzer is the product of Abbott Laboratories (Abbott Park, IL, USA).




Related Links:
Abbott

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.